Mercer Global Advisors
DWTX

Mercer Global Advisors’s Dogwood Therapeutics DWTX Stock Holding History

Mercer Global Advisors’s Portfolio DWTX Stock Details DWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$886 Buy
+550
New +$911 ﹤0.01% 5758

Other funds holding DWTX

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

Mercer Global Advisors's DWTX Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Dogwood Therapeutics (DWTX) in Q2 2026: 550 shares worth $886. The stake represents ﹤0.01% of the portfolio and ranks #5758 among its holdings.

10 funds tracked by Wall St. Rank hold DWTX as of Q2 2026.

  • Mercer Global Advisors held 550 shares of Dogwood Therapeutics worth $886 as of Q2 2026.
  • Dogwood Therapeutics was a new Mercer Global Advisors position in Q2 2026.
  • Dogwood Therapeutics made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5758 holding.
  • 10 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.